Tipton; Kimberly Ann

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tipton; Kimberly Ann.The latest application filed is for "anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof".

Company Profile

9.5.11

Tipton; Kimberly Ann - San Francisco CA
TIPTON; Kimberly Ann - South San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof App 20220306759 - Sagert; Jason Gary ; et al.	2022-09-29
Activatable Anti-CTLA-4 Antibodies and Uses Thereof App 20220089734 - TIPTON; Kimberly Ann ; et al.	2022-03-24
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof Grant 11,267,896 - Sagert , et al. March 8, 2	2022-03-08
Epcam Antibodies, Activatable Antibodies, And Immunoconjugates, And Uses Thereof App 20210403594 - LIU; Yimao ; et al.	2021-12-30
Activatable anti-CTLA-4 antibodies and uses thereof Grant 11,117,968 - Tipton , et al. September 14, 2	2021-09-14
Anti-pd-1 Antibodies, Activatable Anti-pd-1 Antibodies, And Methods Of Use Thereof App 20210179713 - Tipton; Kimberly Ann ; et al.	2021-06-17
Thailanstatin analogs Grant 10,815,246 - Jammalamadaka , et al. October 27, 2	2020-10-27
Thailanstatin Analogs App 20200216463 - JAMMALAMADAKA; Vasu ; et al.	2020-07-09
Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof Grant 10,513,558 - Tipton , et al. Dec	2019-12-24
Activatable Anti-CTLA-4 Antibodies and Uses Thereof App 20190359714 - TIPTON; Kimberly Ann ; et al.	2019-11-28
Thailanstatin Analogs App 20190233430 - Jammalamadaka; Vasu ; et al.	2019-08-01
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof App 20190202927 - Sagert; Jason Gary ; et al.	2019-07-04
Thailanstatin Analogs App 20190084996 - Jammalamadaka; Vasu ; et al.	2019-03-21
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof Grant 10,179,817 - Sagert , et al. Ja	2019-01-15
Anti-pd1 Antibodies, Activatable Anti-pd1 Antibodies, And Methods Of Use Thereof App 20170044259 - Tipton; Kimberly Ann ; et al.	2017-02-16
Anti-cd71 Antibodies, Activatable Anti-cd71 Antibodies, And Methods Of Use Thereof App 20160355599 - Sagert; Jason Gary ; et al.	2016-12-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.